- This event has passed.
Developing a Medical Device: turning your idea into a successful commercial product that’s improving detection, diagnosis or treatment.
Please register with your University of Oxford email address
The University of Oxford is host of a very vibrant research and innovation ecosystem. In the recent year, the Oxford Institute of Biomedical Engineering, through its spin-out Organox, has seen its first therapeutic device, a novel organ preservation device, approved by the FDA in 2021. The device is the results of more than 15 years of cross-disciplinary works between several department at the University and its spin-out. OxVent, a social enterprise from the University of Oxford and King’s College London rapidly developed a deployable and low-cost ventilator due to the accrued needs through the Covid-19 pandemic in a record time. Developing a medical device is however no walk-in the park and require a broad set of knowledge, collaborative work, between scientific, commercial, legal and regulatory teams.
In this webinar series, we intend to bring knowledge, tools and a network to academic researchers developing their own device and ideas at the university. This series aims to support the academic community transitioning from basic and fundamental research into the translational research space, where the bases for a commercial, or non-for profit and impact driven projects, needs to be lay down. Following the 2021 webinar series ‘Developing a Medical Device: turning your idea into a successful commercial product that’s improving detection, diagnosis or treatment’, we will continue the series in 2022 to address topics.
The webinar series will run from the 4th of May to 6th of July 2022, every Wednesday, from 12:00 to 13:00.
The first event will be a pre-recorded session not a live session.
SERIES OF EVENTS:
Session 1 | May 4th: Introduction session: what have we learned in 2021? (Pre- recorded session, attendees will be emailed a video to watch in their own time )
Session 2 | May 11th: Commercialisation strategies: spin-out versus licencing
Session 3 | May 18th: Product development strategies: physical device
Session 4 | May 25th: Product development strategies: medical device diagnostics
Session 5 | June 1rst: Product development strategies: software
Session 6 | June 8th: Product development strategies: active device
Session 7 | June 15th: Product development strategies: single use products
Session 8 | June 22nd: Risk management strategies
Session 9 | June 29th: Clinical data & requirement
Session 10 | July 6th: The evolving regulatory landscape and the impact of Brexit